Curated Wealth Partners
ABBV icon

Curated Wealth Partners’s AbbVie ABBV Stock Holding History

Curated Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.34M Buy
5,130
+1,981
+63% +$508K 0.11% 92
2026
Q2 		$792K Buy
3,149
+1,032
+49% +$222K 0.09% 78
2026
Q1 		$460K Sell
2,117
-50
-2% -$11.1K 0.06% 117
2025
Q4 		$495K Buy
2,167
+582
+37% +$133K 0.05% 120
2025
Q3 		$367K Sell
1,585
-320
-17% -$65.2K 0.04% 113
2025
Q2 		$354K Sell
1,905
-32
-2% -$5.95K 0.04% 115
2025
Q1 		$406K Buy
1,937
+28
+1% +$5.44K 0.05% 102
2024
Q4 		$339K Sell
1,909
-107
-5% -$19.7K 0.04% 108
2024
Q3 		$398K Sell
2,016
-11
-0.5% -$2.05K 0.05% 96
2024
Q2 		$348K Buy
+2,027
New +$336K 0.05% 96
2024
Q1 		– Sell
-2,149
Closed -$370K – 140
2023
Q4 		$333K Sell
2,149
-103
-5% -$15K 0.05% 105
2023
Q3 		$336K Sell
2,252
-325
-13% -$47.7K 0.06% 100
2023
Q2 		$347K Sell
2,577
-238
-8% -$34.9K 0.07% 94
2023
Q1 		$449K Sell
2,815
-124
-4% -$19K 0.1% 74
2022
Q4 		$475K Buy
2,939
+75
+3% +$11.5K 0.12% 67
2022
Q3 		$382K Sell
2,864
-44
-2% -$6.31K 0.11% 80
2022
Q2 		$444K Sell
2,908
-501
-15% -$76.6K 0.13% 73
2022
Q1 		$461K Hold
3,409
– – 0.16% 78
2021
Q4 		$461K Buy
3,409
+39
+1% +$4.61K 0.15% 81
2021
Q3 		$363K Sell
3,370
-136
-4% -$15.5K 0.2% 97
2021
Q2 		$394K Buy
3,506
+929
+36% +$105K 0.21% 89
2021
Q1 		$279K Buy
+2,577
New +$276K 0.17% 112

Other funds holding ABBV

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Curated Wealth Partners's ABBV Position: Q3 2026 in Review

Curated Wealth Partners increased its AbbVie (ABBV) stake by 63% in Q3 2026, buying an estimated $508K and bringing the position to 5,130 shares worth $1.34M. The position accounts for 0.11% of the portfolio, ranked #92.

Curated Wealth Partners first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 3,708 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Curated Wealth Partners held 5,130 shares of AbbVie worth $1.34M as of Q3 2026.
  • Curated Wealth Partners bought 1,981 AbbVie shares in Q3 2026, an estimated $508K.
  • AbbVie made up 0.11% of Curated Wealth Partners's portfolio in Q3 2026, its #92 holding.
  • Curated Wealth Partners first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 3,708 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Curated Wealth Partners's 13F filing for Q3 2026, filed 15 Oct 2026.